No connection

Search Results

ASML vs CLBT

ASML
ASML Holding N.V.
NEUTRAL
Price
$1345.69
Market Cap
$528.4B
Sector
Technology
AI Confidence
78%
CLBT
Cellebrite DI Ltd.
NEUTRAL
Price
$14.15
Market Cap
$3.53B
Sector
Technology
AI Confidence
50%

Valuation

P/E Ratio
ASML
47.17
CLBT
45.65
Forward P/E
ASML
31.14
CLBT
23.19
P/B Ratio
ASML
22.96
CLBT
7.26
P/S Ratio
ASML
16.18
CLBT
7.42
EV/EBITDA
ASML
41.58
CLBT
39.6

Profitability

Gross Margin
ASML
52.83%
CLBT
84.2%
Operating Margin
ASML
35.3%
CLBT
16.15%
Profit Margin
ASML
29.42%
CLBT
16.47%
ROE
ASML
50.46%
CLBT
19.1%
ROA
ASML
14.25%
CLBT
5.1%

Growth

Revenue Growth
ASML
4.9%
CLBT
18.1%
Earnings Growth
ASML
7.2%
CLBT
1.8%

Financial Health

Debt/Equity
ASML
0.24
CLBT
0.05
Current Ratio
ASML
1.26
CLBT
1.56
Quick Ratio
ASML
0.73
CLBT
1.47

Dividends

Dividend Yield
ASML
0.65%
CLBT
--
Payout Ratio
ASML
26.6%
CLBT
0.0%

AI Verdict

ASML NEUTRAL

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

Strengths
Exceptional profitability with 50.46% ROE and 29.42% profit margin
Dominant market position in semiconductor equipment with strong pricing power
Consistent earnings beat rate (50% over last 4 quarters) and positive EPS surprises
Risks
Current valuation at P/E 47.17 and Price/Book 22.96 suggests significant premium to historical norms
Technical trend score of 10/100 indicates short-term bearish momentum despite long-term strength
Dividend strength is weak (25/100), with low yield (0.65%) and modest payout ratio (26.6%)
CLBT NEUTRAL

CLBT shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 7/9). Key strengths include strong valuation and growth metrics. Price trades at a 370.1% premium to fair value estimate ($3.01), limiting near-term upside from a valuation perspective.

Strengths
Strong financial trend (Piotroski F-Score: 7/9)
Strong revenue growth of 18.1%
Low debt with D/E ratio of 0.05
Risks
High valuation with P/E of 45.6
Premium vs Graham Number ($3.69)
Price trades at a 370.1% premium to fair value estimate ($3.01), limiting near-term upside from a valuation perspective.

Compare Another Pair

ASML vs CLBT: Head-to-Head Comparison

This page compares ASML Holding N.V. (ASML) and Cellebrite DI Ltd. (CLBT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile